Working... Menu
Trial record 34 of 724 for:    Botulinum Toxins, Type A

A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb Spasticity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02280083
Recruitment Status : Completed
First Posted : October 31, 2014
Last Update Posted : September 26, 2016
Information provided by (Responsible Party):
Lanzhou Institute of Biological Products Co., Ltd

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2016
  Actual Study Completion Date : September 2016